French firm Valneva has instructed JLL to explore options for its circa 75,000 sq ft Covid-19
vaccine facility in Scotland, including a potential sale. The new Almeida biomanufacturing facility, in Livingston, West Lothian, spans across just over 44,600 sq
Thank you for reading EG
Want to read more? Enjoy a story a week for FREE for one month.
Register
Find Out More